General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Abiomed(SIGNIFICANT), Scilex(MODEST), HeartFlow(MODEST), Regeneron(MODEST) EQUITY INTERESTS/STOCK OPTIONS: Ablative Solutions(NONE)
CONSULTING FEES/HONORARIA: Abiomed(SIGNIFICANT), Scilex(MODEST), HeartFlow(MODEST), Regeneron(MODEST) EQUITY INTERESTS/STOCK OPTIONS: Ablative Solutions(NONE)
© 2024 American College of Cardiology Foundation. All rights reserved.